Blau Lab

HELEN M. BLAU - CURRICULUM VITAE

Honors and Awards Organized Meetings Professional Societies Editorial Boards Honorary Lecture Invitations Experience in Training Administrative: University and Public Service

Dual Citizenship: United States & United Kingdom

Education:

1969 B.A. University of York, York, England
1970 M.A. Harvard University, Cambridge, MA
1975 Ph.D. Harvard University, Cambridge, MA

Professional Experience:

• 1969 - 1975: Predoctoral Fellow, Department of Biology, Harvard University, Cambridge, MA (advisor: F.C. Kafatos)

• 1975 - 1978: Postdoctoral Fellow, Division of Medical Genetics, Departments of Biochemistry and Biophysics, University of California, San Francisco, CA (advisor: C.J. Epstein)

• 1978 - 1986: Assistant Professor, Department of Pharmacology, Stanford University School of Medicine, Stanford, CA

• 1986 - 1991: Associate Professor, Department of Pharmacology, Stanford University School of Medicine, Stanford, CA

• 1991 - present: Professor, Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, CA

• 1997 - 2002: Chair, Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, CA

• 1997 - present: Director, Gene Therapy Technology, Stanford University School of Medicine, Stanford, CA

• 1999 - present: Donald E. and Delia B. Baxter Professor, Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, CA

• 2002 - present: Director, Baxter Laboratory in Genetic Pharmacology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA.

Honors and Awards: top

• Basil O'Connor Faculty Fellow (1978-81)
• Mellon Foundation Faculty Fellow (1979-80)
• William M. Hume Faculty Scholar (1981-84)
• Research Career Development Award, National Institutes of Health (1984-89)
• SmithKline and Beecham Award (1989-91)
• Fellow of the American Association for the Advancement of Science (elected 1991)
• U.S. National Academy of Sciences Delegation to The People's Republic of China (1991)
• Resident Scholar, Bellagio Study Center of Rockefeller Foundation, Lake Como, Italy (1992)
• Senior Career Recognition Award of WICB, American Society of Cell Biology (1992)
• Excellence in Teaching Recognition, Committee on Courses and Curriculum,
• Stanford University School of Medicine (1992-93); (1993-94); (1995-96); (1997-98)
• 54th President, American Society for Developmental Biology (1994-95)
• MERIT Award, National Institutes of Health (1995-2005)
• Yvette Mayent-Rothschild Visiting Professor, Instituts Curie and Pasteur, Paris (1995)
• Institute of Medicine of the National Academy of Sciences (elected 1995)
• Nobel Forum Lecture, Karolinska, Sweden (1995)
• National Advisory Council, NIH Institute on Aging (1996-2000)
• American Academy of Arts and Sciences (elected 1996)
• Initiator and Liaison, Stanford/Aventis Inc. $5 Million Innovative Grant Agreement (1997-02)
• NATO Collaborative Research Programme, France (1997-98)
• Board of Directors, American Society for Gene Therapy (1999-2002)
• FASEB, Excellence in Science Award (1999)
• Donald E. and Delia B. Baxter Endowed Professorship (1999)
• NIH Director's Lectureship (2000)
• International Society of Differentiation - Vice President/President Elect (2000-2006)
• Initiator and P.I. of GenCell-Stanford Collaborative Agreement on Angiogenesis for $12 Million (2001-2005)
• Fellow, American Heart Association, Council on Basic Cardiovascular Sciences (2001)
• McKnight Endowment Fund for Neuroscience Award (2001)
• Council Member, American Society for Cell Biology (ASCB) (2002-2004)
• Honorary Doctorate, University of Nijmegen, Holland (2003)
• Rolf-Sammet-Fonds Visiting Professorship, University of Frankfurt (2003)
• Plenary Speaker on Stem Cells, Pontifical Academy, the Vatican in Rome (2003)
• Council Member, Institute of Medicine (2004-2006)
• Board Member, Harvard Board of Overseers (2004-2010)

Organizer, National and International Meetings: top

• Co-organizer with M. Karin, FASEB Meeting, Regulation of Tissue-Specific Gene Expression (1990)
• Co-organizer with A. Kelly, Keystone Symposium, Gene Expression in Neuromuscular Development (1991)
• Co-organizer with N. Rosenthal, 54th Annual Meeting of the American Society for Developmental Biology (1995)
• Co-organizer with J. Wilson, Keystone Symposium, Molecular and Cellular Biology of Gene Therapy (1997)
• Organizer, Gene Therapy: Prospects for the Next Decade First Gene Therapy Symposium at Stanford (1999)
• International Scientific Advisory Committee, 8th Meeting of the European Society of Gene Therapy (ESGT), Stockholm, Sweden (2000)
• Co-Organizer with W.Mobley and A. Garber, Aging: Biology, Disease and Economics - First Interdisciplinary Aging Symposium at Stanford (2001)
• President/Co-organizer, International Society of Differentiation Meeting, Hawaii (2004)

Professional Societies: top

• American Association for the Advancement of Science
• American Heart Association
• American Society for Biochemistry and Molecular Biology
• American Society for Cell Biology
• American Society for Developmental Biology
• American Society of Gene Therapy
• American Society of Human Genetics
• International Society of Differentiation
• Society for Neuroscience

Editorial Boards: top

• The Journal of Cell Biology (1987-1994)
• Neuromuscular Disorders (1990-1994)
• Molecular and Cellular Biology (1991-1994)
• Developmental Biology, consulting editor (1995-1998)
• Journal of Molecular Medicine (1994-2001)
• Advisory Board, Biochimica et Biophysica Acta Reviews on Cancer (1995-2002)
• Somatic Cell and Molecular Genetics (1988-present)
• Experimental Cell Research (1987-2000)
• Molecular and Cellular Differentiation (1992-present)
• Genes to Cells (Senior Editor, 1994-present)
• Molecular Medicine Today/Trends in Molecular Medicine (1994-present)
• Molecular Therapy (2000-present))
• Molecular Interventions (2000-present)
• Differentiation, Senior Editor (2004-present)
• FASEB Journal, Senior Editor (2005-present)

Selected Honorary Lectureship Invitations (last 5 years): top

• Plenary Speaker, Keystone Symposium: Molecular and Cellular Biology of Gene Therapy, CO (1998)
• Plenary Speaker, Symposium for Molecular Medicine, University of California, San Diego, CA (1998)
• Plenary Speaker, Barbara H. Bowman Memorial Symposium, The University of Texas Health Science Center at San Antonio, TX (1998)
• Plenary Speaker, 57th Annual Meeting, American Society for Developmental Biology, Stanford, CA (1998)
• Invited Speaker, Gordon Research Conference on Myogenesis, Tilton, NH (1998)
• Plenary Speaker, Molecular Interaction Technologies 98, San Francisco, CA (1998)
• Distinguished Woman in Medicine and Science Lecturer, Northwestern University, Chicago, IL (1999)
• Plenary Speaker, Keystone Symposium: Molecular and Cellular Biology of Gene Therapy, UT (1999)
• Plenary Speaker, Keystone Symposium: Molecular and Cellular Biology of Transplantation, NV (1999)
• MSTP Invited Lecturer, Medical College of Wisconsin, Milwaukee, WI (1999)
• Guest Professor, ASPET Teaching Institute, American Society of Gene Therapy Meeting, Washington, DC (1999)
• Invited Speaker, Gordon Research Conference on Wound Repair, Colby-Sawyer College, New London, NH (1999)
• FASEB Excellence in Science Award Lecture, American Society for Cell Biology Annual Meeting, Washington, DC (1999)
• Invited Speaker, American Society for Pharmacology and Experimental Therapeutics (ASPET) Teaching Institute: Pharmacologists of the Future, Washington, DC (1999)
• Plenary Speaker, North American Vascular Biology Organization (NAVBO) Tissue Remodeling in Angiogenesis Symposium, Washington, DC (1999)
• Plenary Speaker, Keystone Symposia: Gene Therapy: The Next Millenium (2000)
• Plenary Speaker, Keystone Symposia: Molecular Biology of the Cardiovascular System (2000)
• Plenary Speaker, 22nd Princeton Conference on Cerebrovascular Disease, Redwood City, CA (2000)
• Invited Lecturer, NIH Director's Lecture Series, Bethesda, MD (2000)
• Biosciences Distinguished Lecturer, Lawrence Berkeley National Laboratory, Berkeley, CA (2000)
• Plenary Speaker, 5th Ben May Institute for Cancer Research Symposium, Univ. Chicago (2000)
• Plenary Speaker, Molecular Biology of Muscle Development and Disease, Asilomar, CA (2000)
• Keynote Speaker, 25th Annual Meeting, Society of Cardiovascular and Interventional Radiology, San Diego, CA (2000)
• Plenary Speaker, 3rd Annual Meeting, American Society of Gene Therapy, Denver, CO (2000)
• Plenary Speaker, European Society for Gene Therapy 8th Meeting, Stockholm, Sweden (2000)
• Invited Speaker, Institut Pasteur, Paris, France (2000)
• Invited Speaker, Department of Cell Biology, Biological Chemistry and Molecular Pharmacology and Institute of Chemistry and Cell Biology, Harvard University (2000)
• Plenary Session Chair, Gene Therapy 2001: A Gene Odyssey, Keystone Symposium, Utah (2001)
• Co-Chair and Speaker, Stem Cell Minisymposium, 41st Meeting of the American Society for Biology, Washington, DC (2001)
• Broadhurst Distinguished Lecturer, Harvard University, Cambridge, MA (2001)
• President's Research Seminar Series Lecturer, Memorial Sloan Kettering Cancer Center, NY (2002)
• Mary Elizabeth Garrett Lecturer, Johns Hopkins University School of Medicine, Baltimore, MD (2002)
• Catherine N. Stratton Lecturer on Critical Issues, Whitehead Institute, Massachusetts Institute of Technology, MA (2002)
• Invited Speaker, Wellcome Institute, Cambridge, U.K. (guest of John Gurdon) (2003)
• Plenary Speaker, British Society for Developmental Biology, Spring Meeting, University of Warwick, England (2003)
• Plenary Speaker, Perlmutter Family Symposium on Neurodegenerative Disorders, Harvard University School of Medicine (2003)
• 2003 Annual Scientist in Medicine Lecture, University of Washington (2003)
• Plenary Speaker, XIIIth International Vascular Biology Meeting, Toronto, Canada (2004)
• Plenary Speaker, 2nd Annual International Society for Stem Cell Research Meeting, Boston, MA (2004)
• President’s Lecture, 13th International Society of Differentiation Conference, Honolulu, HI (2004)
• Keynote Speaker, Allergan Foundation Lectures, Howard A. Schneiderman Memorial Bioethics Lecture Series, University of California, Irvine (2004)
• Louis A. Bloomfield Lecturer, Case Western Research University School of Medicine, Cleveland, OH (2005)

Experience in Training (Students, Postdoctoral Fellows and Medical Residents): top

• Faculty Program, NIH Cancer Biology Predoctoral/Postdoctoral Training Program, Stanford School of Medicine (1978-present)
• Admissions Coordinator, NIH Pharmacology Predoctoral Training Program, Stanford School of Medicine (1981-1988; 1994-1996)
• Program Committee, NIH Neurosciences Predoctoral Training Program at Stanford School of Medicine (1987-1991; 1993-1996); Faculty Preceptor (1998-present)
• Associate Program Director, NIH Developmental & Neonatal Biology Predoctoral and Postdoctoral Training Program at Stanford School of Medicine (1988-present)
• Co-director, CAM (First Stanford Predoctoral Multidepartmental Combined Admission Mode) (1990-1993))
• Faculty Affiliate and Preceptor, NIH Biotechnology Predoctoral Training Program, Stanford School of Medicine (1993-present)
• Special Advisor, Cell Sciences Program, Stanford School of Medicine (1994-present)
• Program Committee, Flexible Graduate Admissions Program at Stanford (1995-1996)
• Head, Task Force on Training, National Institute on Aging, Washington, D.C. (1998-1999)
• P.I. and Director, NIH Pharmacology Predoctoral Training Program, Stanford School of Medicine (1998-2003)
• P.I. and Director, NIH Molecular Pharmacology of Diseases of Aging Predoctoral Training Program, Stanford School of Medicine (1998-2004)
• Member, Women's Reproductive Health Research (WRHR) Career Development Program at Stanford School of Medicine (2000-present)
• Member, Microbiology & Immunology Department Predoctoral/Postdoctoral Training Program (2002-present)
• Faculty Preceptor, Stanford Stem Cell Institiue (2003-present)

Selected Administrative Experience (University and Public Service): top

• Member, ISSCR Education Subcommittee (2003-present))
• Faculty Affiliate, Stanford Cardiovascular Institute (2003-present)
• Genetic Counseling, Department of Medical Genetics, U.C., San Francisco (1975-1978)
• Reproductive Outcome Research for Medfly Health Advisory Committee, State of California (1981-1982)
• Faculty Senator for Dept. of Pharmacology, Academic Senate of Stanford School of Medicine (1982-85)
• Faculty Affiliate, Michelle R. Clayman Institute for Gender Research, Stanford University (1982-present)
• Dean Search Committee, Stanford School of Medicine (1984)
• Nominating Committee, American Society for Cell Biology (1985-1986)
• Faculty Senator-At-Large, Stanford School of Medicine (1986-1989)
• NIH Molecular Cytology Study Section (Ad Hoc) (1987, 1988)
• Steering Committee of the Faculty Senate, "Committee of Five," Stanford School of Medicine (1986-1989)
• Chair, Dean's Advisory Committee on Junior Faculty Awards, Stanford School of Medicine (1987-1989)
• Advisory Board, Program in Molecular and Genetic Medicine at Stanford (1988-1995)
• Chair, Katharine Dexter McCormick Distinguished Lectureship Committee, Stanford (1989-1998)
• NICHD/NIH Five-Year Planning Committee, Genetics & Teratology Branch Washington, D.C. (1989)
• Program Committee, American Society for Cell Biology (1990)
• Executive Committee, Basic Science Council, American Heart Association (1991-1992)
• NIH (RAC) Oversight Committee of Gene Therapy (created by Harold Varmus) (1995)
• 54th President, American Society for Developmental Biology (1995-1996)
• Chair, Nominating Committee, American Society for Biochemistry and Molecular Biology (1996)
• Co-Chair, Dean's Task Force on Gene Therapy, Stanford Medical School (1995-1996)
• National Advisory Council, National Institute on Aging, NIH, Washington, D.C. (1996-2000)
• Board of Directors, American Society of Gene Therapy (1998-2001)
  
• Co-Director (with Mark Kay), Gene Therapy Program, Stanford School of Medicine (1998-present)
• Co-Organizer (with Mark Kay), Frontiers in Stem Cells and Gene Therapy Seminar Series, Stanford (1999-present)
• Co-Organizer, French Rhône-Poulenc Rorer/Stanford Workshop on Gene Therapy (1999))
• American Society for Cell Biology (ASCB), Joint Steering Committee on Public Policy (1999-present)
• Member, Congressional Liaison Committee for Public Policy for ASCB (2000-present)
• Chair, American Society of Gene Therapy, Scientific Committee for 3rd Annual Meeting on Neuromuscular Disorders (2000); Committee Member (2003)
• Organizing Committee, European Society for Gene Therapy 8th Meeting (2000)
• Fellow, American Heart Association, Council on Basic Cardiovascular Sciences (2001-present)
• Chair, Membership Committee, Institute of Medicine (IOM) of the National Academy of Sciences Membership Committee, Section 02 (2002-2003); Vice Chair (2000-2001)
• Membership Committee, American Academy of Arts and Sciences, Class II Biological Sciences, Section 2 (2001, 2002)
• Scientific Planning Committee Member, Conseil Stratégique de l’Association Française contre les Myopathies (AFM) (2001-present)
• Scientific Coordinator, Stanford Interdisciplinary Institute for French Studies (2002-present)
• Member, ISSCR Education Subcommittee (2003-present)
• Faculty Affiliate, Stanford Cardiovascular Institute (2003-present)
• Member, International Society for Stem Cell Research Education Subcommittee (2003-2004)
• Member, Institute of Medicine Nominating Committee (2004)
• Member, IOM Working Group on Physical and Basic Biomedical Sciences, Reorganization of sections (2004)
• Member, Institute for Stem Cell Biology and Regenerative Medicine (2003-present)
• Co-organizer (with Margaret Fuller) Regenerative Medicine and Stem Cells Seminar Series (2005-present)